295 related articles for article (PubMed ID: 18836922)
1. Physicochemical characteristics of aerosol particles generated during the milling of beryllium silicate ores: implications for risk assessment.
Stefaniak AB; Chipera SJ; Day GA; Sabey P; Dickerson RM; Sbarra DC; Duling MG; Lawrence RB; Stanton ML; Scripsick RC
J Toxicol Environ Health A; 2008; 71(22):1468-81. PubMed ID: 18836922
[TBL] [Abstract][Full Text] [Related]
2. Characterization of physicochemical properties of beryllium aerosols associated with prevalence of chronic beryllium disease.
Stefaniak AB; Hoover MD; Day GA; Dickerson RM; Peterson EJ; Kent MS; Schuler CR; Breysse PN; Scripsick RC
J Environ Monit; 2004 Jun; 6(6):523-32. PubMed ID: 15173904
[TBL] [Abstract][Full Text] [Related]
3. Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility.
Kent MS; Robins TG; Madl AK
Appl Occup Environ Hyg; 2001 May; 16(5):539-58. PubMed ID: 11370934
[TBL] [Abstract][Full Text] [Related]
4. Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility.
Deubner D; Kelsh M; Shum M; Maier L; Kent M; Lau E
Appl Occup Environ Hyg; 2001 May; 16(5):579-92. PubMed ID: 11370937
[TBL] [Abstract][Full Text] [Related]
5. Differences in dissolution behavior in a phagolysosomal simulant fluid for single-constituent and multi-constituent materials associated with beryllium sensitization and chronic beryllium disease.
Stefaniak AB; Day GA; Hoover MD; Breysse PN; Scripsick RC
Toxicol In Vitro; 2006 Feb; 20(1):82-95. PubMed ID: 16061346
[TBL] [Abstract][Full Text] [Related]
6. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers.
Schuler CR; Virji MA; Deubner DC; Stanton ML; Stefaniak AB; Day GA; Park JY; Kent MS; Sparks R; Kreiss K
Scand J Work Environ Health; 2012 May; 38(3):270-81. PubMed ID: 21877099
[TBL] [Abstract][Full Text] [Related]
7. A comparison and critique of historical and current exposure assessment methods for beryllium: implications for evaluating risk of chronic beryllium disease.
Kolanz ME; Madl AK; Kelsh MA; Kent MS; Kalmes RM; Paustenbach DJ
Appl Occup Environ Hyg; 2001 May; 16(5):593-614. PubMed ID: 11370938
[TBL] [Abstract][Full Text] [Related]
8. Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant.
Madl AK; Unice K; Brown JL; Kolanz ME; Kent MS
J Occup Environ Hyg; 2007 Jun; 4(6):448-66. PubMed ID: 17474035
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of beryllium exposure to small particles at a beryllium production facility.
Virji MA; Stefaniak AB; Day GA; Stanton ML; Kent MS; Kreiss K; Schuler CR
Ann Occup Hyg; 2011 Jan; 55(1):70-85. PubMed ID: 20805261
[TBL] [Abstract][Full Text] [Related]
10. Characterization of exposures among cemented tungsten carbide workers. Part I: Size-fractionated exposures to airborne cobalt and tungsten particles.
Stefaniak AB; Virji MA; Day GA
J Expo Sci Environ Epidemiol; 2009 Jul; 19(5):475-91. PubMed ID: 18628793
[TBL] [Abstract][Full Text] [Related]
11. Dissolution of beryllium in artificial lung alveolar macrophage phagolysosomal fluid.
Stefaniak AB; Virji MA; Day GA
Chemosphere; 2011 May; 83(8):1181-7. PubMed ID: 21251696
[TBL] [Abstract][Full Text] [Related]
12. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.
Schuler CR; Kent MS; Deubner DC; Berakis MT; McCawley M; Henneberger PK; Rossman MD; Kreiss K
Am J Ind Med; 2005 Mar; 47(3):195-205. PubMed ID: 15712254
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
[TBL] [Abstract][Full Text] [Related]
14. Beryllium Exposure Control Program at the Cardiff Atomic Weapons Establishment in the United Kingdom.
Johnson JS; Foote K; McClean M; Cogbill G
Appl Occup Environ Hyg; 2001 May; 16(5):619-30. PubMed ID: 11370940
[TBL] [Abstract][Full Text] [Related]
15. Dissolution and nanoparticle generation behavior of Be-associated materials in synthetic lung fluid using inductively coupled plasma mass spectroscopy and flow field-flow fractionation.
Huang W; Fernandez D; Rudd A; Johnson WP; Deubner D; Sabey P; Storrs J; Larsen R
J Chromatogr A; 2011 Jul; 1218(27):4149-59. PubMed ID: 21167491
[TBL] [Abstract][Full Text] [Related]
16. Particle size distribution and respiratory deposition estimates of beryllium aerosols in an extraction and processing plant.
Thorat DD; Mahadevan TN; Ghosh DK
AIHA J (Fairfax, Va); 2003; 64(4):522-7. PubMed ID: 12908869
[TBL] [Abstract][Full Text] [Related]
17. Introduction to beryllium: uses, regulatory history, and disease.
Kolanz ME
Appl Occup Environ Hyg; 2001 May; 16(5):559-67. PubMed ID: 11370935
[TBL] [Abstract][Full Text] [Related]
18. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 1: historical exposure reconstruction.
Virji MA; Park JY; Stefaniak AB; Stanton ML; Day GA; Kent MS; Kreiss K; Schuler CR
Scand J Work Environ Health; 2012 May; 38(3):247-58. PubMed ID: 21850365
[TBL] [Abstract][Full Text] [Related]
19. Surface area of respirable beryllium metal, oxide, and copper alloy aerosols and implications for assessment of exposure risk of chronic beryllium disease.
Stefaniak AB; Hoover MD; Dickerson RM; Peterson EJ; Day GA; Breysse PN; Kent MS; Scripsick RC
AIHA J (Fairfax, Va); 2003; 64(3):297-305. PubMed ID: 12809534
[TBL] [Abstract][Full Text] [Related]
20. A theoretical framework for evaluating analytical digestion methods for poorly soluble particulate beryllium.
Stefaniak AB; Brink CA; Dickerson RM; Day GA; Brisson MJ; Hoover MD; Scripsick RC
Anal Bioanal Chem; 2007 Apr; 387(7):2411-7. PubMed ID: 17124574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
